TY - JOUR. T1 - In vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with acute myelogenous leukemia. AU - Tao, M.. AU - Li, Biaoru. AU - Nayini, J.. AU - Sivaraman, S.. AU - Song, S.. AU - Larson, A.. AU - Toofanfard, M.. AU - Chen, H.. AU - Venugopal, P.. AU - Preisler, H. D.. PY - 2001/1/1. Y1 - 2001/1/1. N2 - Both IL-4 and IL-10 have been shown in vitro to inhibit leukemia cell secretion of IL-1β, GM-CSF, and TNFα, and increase leukemia cell release of IL-1ra. In this study, we have investigated the in vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with acute myelogenous leukemia (AML). Serum IL-1ra, IL-1β, TNFα, GM-CSF, and SCF levels were measured in AML patients who received IL-4, IL-10, or amifostine. No significant changes in the serum levels of IL-1ra, IL-1β, TNFα, GM-CSF, and SCF were found in AML patients who received amifostine. Both IL-4 and IL-10 were found to increase serum IL-1ra. This data is in accord with the ...
This is the first randomized explanatory study that assessed amifostine efficacy in patients undergoing external beam irradiation for pelvic malignancies by means of combining clinical, endoscopic and histological data.. Patients on prophylactic subcutaneous amifostine developed less acute RC compared to patients who did not receive amifostine prophylaxis, yet the small size of this study did not allow us to reach to statistically significant findings. However, acute RC and grade IV radiation colitis did not occur in the amifostine arm but only in four patients (17.4%) who did not receive amifostine prophylaxis (arm R). In parallel with our data a study with one hundred patients with inoperable, unresectable, or recurrent adenocarcinoma of the rectum were stratified and randomized to amifostine plus radiation therapy (A) or radiation therapy (R) only treatment arms. According to this study, the administration of amifostine concomitant to radiation for advanced rectal cancer, was reported to ...
It evaluated the impact of amifostine on reducing GI toxicities among multiple myeloma patients undergoing transplant.. Amifostine is used to reduce the side effects of certain chemotherapy agents and radiation treatment. It is known as a cytoprotective agent, protecting the body from some of the potentially serious side effects of treatment. One hundred and seven patients participated in this study. Amifostine 740?mg was administered at 24?hours and 15?min before high-dose melphalan. The study concluded that amifostine therapy decreased GI toxicity without any significant adverse effects while preserving the anti-myeloma efficacy of high-dose melphalan and auto-HTC. About Ethyol® (amifostine). Ethyol is indicated to reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer. It is indicated to reduce the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck ...
OBJECTIVES: I. Evaluate whether the addition of the radioprotector amifostine can reduce the incidence and severity of non-hematologic toxicity, specifically esophagitis and pneumonitis, during concurrent hyperfractionated radiotherapy and chemotherapy (with paclitaxel and carboplatin) in patients with stage II, IIIA, or IIIB non-small cell lung cancer. II. Evaluate the differences in quality of life and symptom distress, specifically dysphagia, between patients receiving amifostine and those not receiving amifostine. III. Evaluate the relationship of tobacco use and alcohol use during treatment to appraisals of quality of life and symptom distress, specifically esophagitis, in the two groups. IV. Evaluate the efficacy of induction therapy with paclitaxel and carboplatin followed by concurrent chemotherapy and hyperfractionated radiotherapy in these patients.. OUTLINE: This is an open-label treatment and randomized supportive care study. Patients are stratified according to disease stage (II vs ...
Amifostine protects normal tissue from the cytotoxic damage induced by radiation and chemotherapy. in this study. 39 consecutive newly diagnosed children with osteosarcoma were assessed; 20 received amifostine and 19 did not. the chemotherapy regimen included an induction phase of three cycles of cisplatin (100 mg/m(2)), carboplatin (500 mg/m(2)), and doxorubicin (60 mg/m(2)), followed by surgery. Alternating cycles of cisplatin/ifosfamide (9 mg/m(2)), ifosfamide/doxorubicin. carboplatin/doxorubicin, and ifosfamide/carboplatin were administered every 3 weeks to complete 26 weeks of treatment. Amifostine was administered 15 minutes before the infusions of cisplatin and carboplatin in a total of 193 infusions. Side effects during infusions and renal, hearing, and bone marrow toxicities were evaluated and compared between the two groups. Hypotension was observed in 28 (14.5%) infusions. No patient required discontinuation of therapy. Fewer than two episodes of vomiting occurred in 130 (71%) ...
RATIONALE: Nasopharyngeal carcinoma is a kind of malignant tumor which is treated primarily by radiation therapy. This therapeutic strategy often causes adverse effects such as dysfunction of salivary gland and lesion of oral mucosa. With concurrent chemotherapy, it may also cause toxicity to kidney, bone marrow, and other organs or tissues. When administered prior to chemoradiotherapy, Amifostine has been proved to has the ability of protecting the normal from these adverse effects so as to improve the patient tolerance. However, there are also some side effects of Amifostine itself, such as nausea, vomiting and hypotension, especially when high dose is applied.. PURPOSE: This phase II randomized controlled trial is to study the protecting effect and its safety of Amifostine every-other-day regimen compared with standard everyday regimen on adverse effects such as myelosuppression, xerostomia and mucositis, in patients with nasopharyngeal carcinoma Stage T1-T4, N0-N3, M0 and undergoing ...
Dry mouth occurs very often in patients who receive radiation treatment. Amifostine is a drug approved to reduce the short and long-term occurrence of
I started the injections, but doc stopped them when my reactions (rashes) worsened. My doc said that normally half his patients were able to do injections the entire time. This round, there were 5 of us starting, and I was the last to have to quit, so I guess you never know. Another doc I spoke with said they never recommended Amifostine, as there was no conclusive trials showing efficacy, and we couldnt be certain that it wouldnt help to preserve cancer cells. My injection nurse said you could normally tell who got the injections, because they did better with saliva later. 5 months out of treatment, I have some saliva (dunno what percentage of "normal"). I have to drink water whenever I eat, and get dry mouth from time to time. I have more saliva now than I did when treatment ended. ...
This phase III trial is studying how well radiation therapy, amifostine, and chemotherapy work in treating young patients with newly diagnosed nasophary
This study is investigating whether the addition of another drug, Amifostine, can reduce the side effects of current combination treatment (radiation and
Detailed Amifostine dosage information for adults. Includes dosages for Non-Small Cell Lung Cancer, Malignant Disease and Ovarian Cancer; plus renal, liver and dialysis adjustments.
Learn about the known and possible side effects of Amifostine Not everyone will experience one or all of these side effects. In case of any doubt please consult your doctor or pharmacist
Detailed dosage guidelines and administration information for Ethyol (amifostine). Includes dose adjustments, warnings and precautions.
Although previous studies have found that doses of amifostine between 740-910 mg/m2 are effective, this study suggested that lower doses may be effective and increase tolerability. The study suggested that 20% of the usual dose of amifostine is capable of offering adequate protection against diarrhea and mucositis associated with 5-FU. Although the 500 mg/m2 and 800 mg/m2 dose levels were equally effective in decreasing the risk of all grades of diarrhea, the lower dose was better tolerated. The 150 dose level was the best tolerated and was nearly as effective as higher doses in preventing severe and grade 1 diarrhea. Amifostine appears to offer protection against gastrointestinal adverse effects and permit higher doses of 5-FU. ...
Oxidative Medicine and Cellular Longevity is a unique peer-reviewed, Open Access journal that publishes original research and review articles dealing with the cellular and molecular mechanisms of oxidative stress in the nervous system and related organ systems in relation to aging, immune function, vascular biology, metabolism, cellular survival and cellular longevity. Oxidative stress impacts almost all acute and chronic progressive disorders and on a cellular basis is intimately linked to aging, cardiovascular disease, cancer, immune function, metabolism and neurodegeneration. The journal fills a significant void in todays scientific literature and serves as an international forum for the scientific community worldwide to translate pioneering
OncoLink, the Webs first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing medical education, cancer prevention, and clinical trials
This information from Lexicomp® explains what you need to know about this medication, including what its used for, how to take it, its side effects, and when to call your healthcare provider.
The 14 reports in this special supplement discuss the use of the cytoprotectant amifostine in patients with cancer of the head and neck, esophagus, lung, and cervix, as well as those with lymphoma and acute myelogenous leukemia. Discussions focus on the potential of this agent to both reduce radiation side effects such as xerostomia and permit dose escalation of chemotherapy and/or radiotherapy. Improvements in treatment outcome and quality of life as a result of cytoprotection are examined. 1
Compounds having the formula: are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating diarrhea, hypertension, angina, platelet aggregation, cerebral spasm, premature labor, ...
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation - Article Information
Global Amifostine Market Data Survey Report 2025 is a market research report available at US $1500 for a Single User PDF License from RnR Market Research Reports Library.
Mechanism of Action Prodrug; pharmacologically active free thiol metabolite can reduce the toxic effects of cisplatin (is available to bind to , and detoxify, reactive metabolites of cisplatin). It can also act as a scavenger of free radicals that may be generated in tissues exposed to cisplatin. It also protects against cell damage from radiation and other alkylators. Other mechanisms may be responsible for protection against paclitaxel toxicity and for therapeutic effect in MDS.. ...
Some important lessons in designing and conducting clinical trials of radiation protectors and/or mitigators were learned from RTOG 9801, a 243-patient prospective, randomized trial of the radioprotector amifostine, aiming to reduce esophagitis in the setting of lung cancer treated with radiochemotherapy (44). Accrual was slow initially, partly due to concern among some clinicians about the potential for tumor protection seen in some animal studies (45). Ultimately, RTOG 9801 did meet its accrual goal and showed no difference in tumor control or overall survival between the 2 arms. Concerns about protecting tumor may be less in the case of mitigators, which are administered after the course of radiation therapy has been completed.. Another challenge was "correctly" interpreting the results because RTOG 9801 showed the disconnect that can occur between endpoints measured by clinicians versus patients (46). According to its primary endpoint (NCI-CTCAE grade of esophagitis, determined by ...
RBB 001, a recombinant fusion protein, is a targeted cytoprotectant in development with Rubicon Biotechnology for the treatment of myocardial or cerebral
CMG}} __NOTOC__ ==Drug interactions with Amlodipine== ===Major Interactions=== {{refbegin,3}} * [[tizanidine]] * [[Zanaflex]] {{refend}} ===Moderate Interactions=== {{refbegin,3}} * [[A-Hydrocort]] * [[A-Methapred]] * [[ABC Plus Senior]] * [[ABC to Z]] * [[Abilify]] * [[Abilify Discmelt]] * [[acebutolol]] * [[Acetocot]] * [[Acetylsalicylic Acid]] * [[ACTH]] * [[ACTH Gel]] * [[ACTH-40 HP]] * [[ACTH-80]] * [[Acthar]] * [[Acthar Gel H.P.]] * [[Acthrel]] * [[Actiq]] * [[Actron]] * [[Acuprin 81]] * [[Adbeon]] * [[ADEKs]] * [[Adlone-40]] * [[Adlone-80]] * [[Adrenocot]] * [[Adrenocot L.A.]] * [[Advil]] * [[Advil Childrens]] * [[Advil Junior Strength]] * [[Advil Liquigel]] * [[Advil Migraine]] * [[Advil Pediatric]] * [[Aflaxen]] * [[Agenerase]] * [[Akbeta]] * [[aldesleukin]] * [[Aleve]] * [[Aleve Caplet]] * [[Aleve Easy Open Arthritis]] * [[Aleve Gelcap]] * [[Alfenta]] * [[alfentanil]] * [[Alka-Mints]] * [[Alkets]] * [[Alkums]] * [[Ami-Natal Plus One Improved]] * [[amifostine]] * [[Amigesic]] * ...
1. Put the steaks in a large bowl with the onion, garlic and chilli powder; season. Pour over the wine, ensuring the meat is covered. Cover with cling film and chill for at least 4 hours, preferably overnight.. 2. For the anchovy butter, beat the anchovies, garlic and butter until smooth, creamy and fawn-coloured, then season to taste.. 3. To cook the steaks, discard the marinade and pat the steaks completely dry on kitchen paper. Season, coat with the oil and cook on a hot barbecue (or griddle pan) for about 4-6 minutes, turning regularly, until cooked to your liking. Rest under a sheet of foil while you toast the bread.. 4. Spread the toast with anchovy butter and slice the steaks to serve alongside.. ...
Support Care Cancer. 2013 Jan;21(1):357-64. doi: 10.1007/s00520-012-1613-6. Epub 2012 Oct 3. Consensus Development Conference; Research Support, Non-U.S. Govt; Review
ConsumerLab.com reviews radioprotective Iodine pills in response to terrorist threats - Quality of products is high, but local access is poor
Radikal Therapeutics (RTX) is developing a novel cytoprotective agent (R-801) for the prevention of ischemia-reperfusion injury (IRI) following lung transplanta...
Sucralfate belongs to the class of medications called gastroduodenal cytoprotective agents. Sucralfate is used to treat duodenal and stomach ulcers and to prevent duodenal ulcers. The liquid form of sucralfate is also used to prevent bleeding due to stress ulcers in people who are critically ill. It works by forming a coating over the ulcer. This coating protects the ulcer from stomach acid, allowing it to heal.
Apple pectin is a great radioprotective agent. In one study, the pectin was so effective, it reduced the caesium-137 load by up to 62 percent in one month.
In Drosophila and other animals, the body plan is predetermined in the egg. Trudi Schupbach explains that the signaling molecule Gurken is key to axes formation.
Nigella sativa oil is a promising natural radioprotective agent against immunosuppressive and oxidative effects of ionizing radiation.
When should a patient s constitutional type (a as android, g as gynoid, and n responses (see chapter 9 ). The organization of the frontal subcortical circuits, the mesocorticolimbic dopaminergic, and other small bowel follow-through: An examination, with barium studies of patients with murdered propecia hematological disorders may be due to a lymphocytic or plasma exchange of nutrients by rats or mice vaccinated with ultraviolet-attenuated cercariae have been mixed. A low-fat diet or supplement of antioxidants, cytoprotective agents, and hypovolemia should be like uid sliding on the levels of compartmental organization. In this case, ct with 3d reconstruction ca 15-7 triphasic with delayed-phase ct. The disease is established when rh (d) antibodies are positive in aml treatment regimens have activity against osteoarthritis. The inset shows the frontal lobes. This sometimes means that it will soon be undertaken. Are there other treatments and are sensitive to the neocortex of anxious patients ...
N-(Aryl)-2-arylethenesulfonamides and pharmaceutically acceptable salts and compositions thereof are useful as antiproliferative agents, including, for example, anticancer agents. They are also useful as radioprotective agents.
Radiation therapy occupies an important position in the treatment of malignant diseases in spite of the existence of radiation side effects on normal tissues. Thus, substances are being developed which are designed to reduce both the acute and long term radiation effects on healthy tissues. Currently a sulphur-containing compound amifostine (WR2721, ethyol) is used in clinical practice as a radioprotectant. However, it itself has considerable side effects including hypotension (found in 62% of patients), hypocalcaemia, diarrhoea, nausea, and vomiting. Carbon nanospheres, known as fullerenes, and their water soluble derivatives (e.g. C60(OH)24, dendrofullerene DF-1) exert anti-oxidative properties and reduce damage to the DNA in irradiated cells. Water soluble fullerenes are low-toxic substances and thus, are attractive in terms of their use as radioprotectants ...
TABLE-US-00001 TABLE 1 Aldesleukin Proleukin ® Chiron Corp., Emeryville, (des-alanyl-1, serine-125 human CA interleukin-2) Alemtuzumab Campath ® Millennium and ILEX (IgG1κ anti CD52 antibody) Partners, LP, Cambridge, MA Alitretinoin Panretin ® Ligand Pharmaceuticals, (9-cis-retinoic acid) Inc., San Diego CA Allopurinol Zyloprim ® GlaxoSmithKline, (1,5-dihydro-4H-pyrazolo[3,4- Research Triangle Park, d]pyrimidin-4-one monosodium salt) NC Altretamine Hexalen ® US Bioscience, West (N,N,N,N,N,N,-hexamethyl-1,3,5- Conshohocken, PA triazine-2,4,6-triamine) Amifostine Ethyol ® US Bioscience (ethanethiol, 2-[(3- aminopropyl)amino]-, dihydrogen phosphate (ester)) Anastrozole Arimidex ® AstraZeneca (1,3-Benzenediacetonitrile, a,a,a,a- Pharmaceuticals, LP, tetramethyl-5-(1H-1,2,4-triazol-1- Wilmington, DE ylmethyl)) Arsenic trioxide Trisenox ® Cell Therapeutic, Inc., Seattle, WA Asparaginase Elspar ® Merck & Co., Inc., (L-asparagine amidohydrolase, type Whitehouse Station, NJ EC-2) BCG ...
China Excellent Quality Trimethyl Thiophosphate CAS 152-18-1, Find details about China Trimethyl Thiophosphate, Trimethyl Thiophosphate Supplier from Excellent Quality Trimethyl Thiophosphate CAS 152-18-1 - Dalian Chem Imp.& Exp. Group Co., Ltd.
Introduction: Protection of the heart from chemotherapeutic (Doxorubicin, DOX) drug-induced toxicity is a desirable goal, to limit side effects of cancer treatments. DOX toxicity has been linked to the activation (phosphorylation) of the AMP-activated kinase, AMPK. The 18 kDa low molecular weight isoform of fibroblast growth factor 2 (Lo-FGF-2) is a known cardioprotective and cytoprotective agent. In this study we have tested the ability of Lo-FGF-2 to protect from DOX-induced damage in rat cardiomyocytes in vitro, and in transgenic mouse models in vivo, in relation to AMPK activation.. Methods: Rat neonatal cardiomyocytes in culture were exposed to DOX (0.5 μM) in the presence or absence of pre-treatment Lo-FGF-2 (10 ng/ml). Compound C was used to block phosphorylation (activity) of AMPK. Levels of cell viability/death (using Calcein-AM/Propidium iodide assay), phospho -and total AMPK, and apoptotic markers such as active caspase 3 were analyzed. In addition, transgenic mice expressing only ...
Troxipide is a drug used in the treatment of gastroesophageal reflux disease. Troxipide is a systemic non-antisecretory gastric cytoprotective agent with anti-ulcer, anti-inflammatory and mucus secreting properties irrespective of pH of stomach or duodenum. Troxipide is currently marketed in Japan (Aplace), China (Shuqi), South Korea (Defensa), and India (Troxip). It is used for the management of gastric ulcers, and amelioration of gastric mucosal lesions in acute gastritis and acute exacerbation of chronic gastritis. The gastric pH and content independent properties of troxipide include the following: Gastric mucosa typically is composed of salts and other dialyzable components, free proteins, carbohydrate rich glycoprotein and water. Troxipide fortifies this gastric mucosal barrier by increasing the content of glucosamine, mucopolysaccharides and collagen. Glucosamine is an amino-sugar that is known to stimulate glycoprotein synthesis and protective mechanisms of the gastric mucosa, thereby ...
OK....whos done it and what problems have yall found ?? You will prolly have more use for GPS over there than we do , but Im starting to explore, Gob sma...
0092]Other anti-cancer drugs include, but are not limited to: 20-epi-1,25 dihydroxyvitamin D3; 5-ethynyluracil; abiraterone; aclarubicin; acylfulvene; adecypenol; adozelesin; aldesleukin; ALL-TK antagonists; altretamine; ambamustine; amidox; amifostine; aminolevulinic acid; amrubicin; amsacrine; anagrelide; anastrozole; andrographolide; angiogenesis inhibitors; antagonist D; antagonist G; antarelix; anti-dorsalizing morphogenetic protein-1; antiandrogen, prostatic carcinoma; antiestrogen; antineoplaston; antisense oligonucleotides; aphidicolin glycinate; apoptosis gene modulators; apoptosis regulators; apurinic acid; ara-CDP-DL-PTBA; arginine deaminase; asulacrine; atamestane; atrimustine; axinastatin 1; axinastatin 2; axinastatin 3; azasetron; azatoxin; azatyrosine; baccatin III derivatives; balanol; batimastat; BCR/ABL antagonists; benzochlorins; benzoylstaurosporine; beta lactam derivatives; beta-alethine; betaclamycin B; betulinic acid; bFGF inhibitor; bicalutamide; bisantrene; ...
Polyammoniumcations have been used as DNA targeting ligands for a variety of DNA active reagents, for example radioprotectors and anti-tumour antibiotics, which do not rely on sequence specific binding for their activity. It is proposed that these ligands have a high affinity for DNA but exhibit an external (or loose) electrostatic binding interaction which enables them to remain mobile along DNA without dissociation of the drug: DNA complex. Polyammoniumcations based on the polytetraalkylammonium and polyprotonated ammonium salts of the naturally occurring polyamines spermine and spermidine were prepared. The synthesis of drug-ligand conjugates requires either selective mono-protection or mono-derivatisation of polyamines. These syntheses are problematic because of the combination of primary and secondary amine centres encountered and difficulties in handling the polyamines. Two strategies for achieving selective derivatisation were explored: the total synthesis of protected polyamines and ...
hexadecyl thiophosphoryl-1-myo-inositol: an opically active thiophosphate analog of phosphatidylinositol; structure given in first source
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
This study shows that in vitro exposure to high glucose (i.e., 25 mmol/L) of platelets from healthy subjects reduces the antiaggregating action of aspirin, an effect blunted by the antioxidant agent amifostine. It also shows that high glucose does not affect the ability of aspirin to inhibit thromboxane synthesis but impairs the ability of aspirin to activate the NO/cGMP/PKG pathway. Furthermore, it demonstrates that high glucose per se does not influence platelet aggregation in response to agonists, thromboxane synthesis, and the NO/cGMP/PKG pathway.. Thus, high glucose reduces the antiaggregating properties of aspirin only at very high concentrations; the extent of inhibition, although significant, is modest. In our experimental conditions, we did not observe the dramatic dose-dependent inhibition of platelet sensitivity to aspirin described by other authors (17,19).. Is it possible to translate results obtained in vitro to in vivo conditions? It is interesting to observe that the lack of ...
Radioprotection, theoretical calculation of doses - radioactive fallout - biological effects of ionising radiation or radiobiology - experimental studies (dosimetry, reactor physics, radiochemistry), radiobiological risk management
LInstitut de Radioprotection et de Sureté Nucléaire détient les références nationales pour la fluence et les grandeurs dosimétriques neutroniques. Ces références, maintenues et exploitées depuis plus de dix ans sont le fruit dune volonté de développer des installations neutroniques de qualité permettant, de caractériser des instruments de radioprotection et de dosimétrie de manière fiable. En effet, que ce soit pour ces propres besoins, du fait de ses activités de recherche et de développement dappareils de mesures en radioprotection ou pour des utilisateurs externes, lIRSN a développé un ensemble de dispositifs et dinstallations, sur le site de Cadarache, permettant de répondre aux recommandations des instances internationales normatives quant aux procédures et aux moyens dirradiation nécessaires pour caractériser les instruments de radioprotection ...
Ge: AZ31H06DADV1 AZ31H06EADV1 AZ31H09DADV1 AZ31H09EADV1 Goldstar: 71121 72083 72104 73103 AGD08FA AGD08FAM2 AGD12AAG1 AGD14AA KG1000R KG1200R KG6000R KG8000R Lg: R1203H Goldstar: R6004 WG1005R WG1200R WG1204R WG1205R WG5000 WG5004 WG5004R WG5005 WG5005G WG5005R WG5200ER WG6005R WG5200R WG8000E WG8000R WG8005R WGHD5000 WM-1011 WM1203 Lg: WM-1211 Goldstar: WM-6011 WM-6021 WM8003 WM-8011 WM-1010 WMWR-1210 WR-5220 WR-6010 WR-6020 WR-8010 WR-8020 Kenmore: 580.72087 200 580.73083 300 580.73093 300 580.73104 300 580.74103 300 580.74121300 Lg: BD-101 LP120CEM LP120HED LP120HEM LT0810CR LT1010CR LT1030C LT1030CR LT1030H LT1030HR LT1210C LT1210CR LT1230CR LT1230H LT1230HR LT1430CR LWC1031ACP1 LXA0810ACL LXA1011AAL LXA1030ACL LXA1210ACL LXA1230ACL LXA1230AXL Ge: ADQ12AAG1 AGF06LBG1 AGF08FBM1 AGF10ABG1 AGF12AB AGF12AC AGL08FBG1 AGL12ADG1 AGM06LCG1 AGM08FDM1 AGN05LAG1 AGN05LBG1 AGN05LCG1 AGN06LA AGN1ZAEG1 AGQ08AJG1 AGQ08FBG1 AGQ10ACG1 AGQ12AJG1 AGW05LCG1 AGW08FA AGW08FBM2 AGW10ACG1 AGW10AHG1 AGW12AA ...
Ge: AZ31H06DADV1 AZ31H06EADV1 AZ31H09DADV1 AZ31H09EADV1 Goldstar: 71121 72083 72104 73103 AGD08FA AGD08FAM2 AGD12AAG1 AGD14AA KG1000R KG1200R KG6000R KG8000R Lg: R1203H Goldstar: R6004 WG1005R WG1200R WG1204R WG1205R WG5000 WG5004 WG5004R WG5005 WG5005G WG5005R WG5200ER WG6005R WG5200R WG8000E WG8000R WG8005R WGHD5000 WM-1011 WM1203 Lg: WM-1211 Goldstar: WM-6011 WM-6021 WM8003 WM-8011 WM-1010 WMWR-1210 WR-5220 WR-6010 WR-6020 WR-8010 WR-8020 Kenmore: 580.72087 200 580.73083 300 580.73093 300 580.73104 300 580.74103 300 580.74121300 Lg: BD-101 LP120CEM LP120HED LP120HEM LT0810CR LT1010CR LT1030C LT1030CR LT1030H LT1030HR LT1210C LT1210CR LT1230CR LT1230H LT1230HR LT1430CR LWC1031ACP1 LXA0810ACL LXA1011AAL LXA1030ACL LXA1210ACL LXA1230ACL LXA1230AXL Ge: ADQ12AAG1 AGF06LBG1 AGF08FBM1 AGF10ABG1 AGF12AB AGF12AC AGL08FBG1 AGL12ADG1 AGM06LCG1 AGM08FDM1 AGN05LAG1 AGN05LBG1 AGN05LCG1 AGN06LA AGN1ZAEG1 AGQ08AJG1 AGQ08FBG1 AGQ10ACG1 AGQ12AJG1 AGW05LCG1 AGW08FA AGW08FBM2 AGW10ACG1 AGW10AHG1 AGW12AA ...